ImCheck Therapeutics Appoints Dr. Loui Madakamutil as CSO
15 avr. 2021 05h00 HE
|
ImCheck Therapeutics SAS
ImCheck Therapeutics Appoints Dr. Loui Madakamutil, Noted Expert in Immunology and Autoimmune Diseases, as Chief Scientific Officer Marseille, France, April 15, 2021 – ImCheck Therapeutics today...
ProQR Appoints Naveed Shams, MD, PhD as Chief Scientific Officer
05 oct. 2020 07h00 HE
|
ProQR Therapeutics N.V.
LEIDEN, Netherlands & CAMBRIDGE, Mass., Oct. 05, 2020 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated to changing lives through the creation of...
Freeline announces promotion of Romuald Corbau, Ph.D. to Chief Scientific Officer
28 sept. 2020 07h00 HE
|
Freeline Therapeutics
LONDON, Sept. 28, 2020 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the “Company” or “Freeline”), a clinical-stage, fully integrated, next generation, systemic, AAV-based...
RenovaCare Appoints Founding Director of BARDA Dr. Robin A. Robinson to Chief Scientific Officer
26 mai 2020 08h30 HE
|
RenovaCare, Inc.
ROSELAND, N.J., May 26, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration...
Rubius Therapeutics Appoints Internationally Recognized Autoimmunity and Translational Immunology Leader Laurence Turka, M.D., as Chief Scientific Officer
08 janv. 2020 08h00 HE
|
Rubius Therapeutics
CAMBRIDGE, Mass., Jan. 08, 2020 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a clinical-stage biopharmaceutical company that is genetically engineering red blood cells to create an...
CURE Pharmaceutical Promotes Dr. Vered Gigi to Chief Scientific Officer
01 oct. 2019 07h25 HE
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., Oct. 01, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, has appointed Dr. Vered Gigi as its chief scientific officer....
Translate Bio Appoints Richard Wooster as Chief Scientific Officer
08 avr. 2019 07h30 HE
|
Translate Bio, Inc.
LEXINGTON, Mass., April 08, 2019 (GLOBE NEWSWIRE) -- Translate Bio, Inc. (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially...
Gamma-Delta T Cell Immunotherapy Pioneer, Lawrence Lamb, PhD, to Join Incysus Therapeutics as Chief Scientific Officer
03 janv. 2019 14h30 HE
|
Incysus Therapeutics, Inc.
NEW YORK, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Incysus Therapeutics, Inc. (“Incysus”), a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the...
Renown Health Appoints Joseph Grzymski, Ph.D., as Chief Scientific Officer
25 sept. 2018 08h00 HE
|
Renown Health
Reno, Nev., Sept. 25, 2018 (GLOBE NEWSWIRE) -- Taking the next step toward expanding its landmark population health and genetics research initiative to a statewide and national level, Renown Health...
Dr. Johnny Huard named Chief Scientific Officer of Steadman Philippon Research Institute
08 juin 2015 08h04 HE
|
The Steadman Clinic
VAIL, Colo., June 8, 2015 (GLOBE NEWSWIRE) -- Johnny Huard, PhD, former Vice Chair for Musculoskeletal Cellular Therapeutics, Department of Orthopedic Surgery, Director of the Stem Cell Research...